Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Celebrating neuroscience in spring 2023 Date 4 August 2022 We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Parkinson’s UK celebrity ambassador David ‘Kid’ Jensen takes part in world-first clinical trial Date 22 July 2022 Broadcasting legend and Parkinson's UK celebrity ambassador David ‘Kid’ Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson’s or Lewy body dementia.
Caption People sit around a table for a group discussion Understanding symptoms early after Parkinson’s diagnosis Date 19 July 2022 An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
Progress towards Apple Watch based tracking of symptoms Date 17 June 2022 An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson’s.
Save Parkinson’s clinical research. Take part today Date 8 June 2022 We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Caption Drug discovery research NRG Therapeutics awarded £2.68m to develop treatments that could slow Parkinson's Date 30 May 2022 Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Researchers find brain scans linked to the severity of Parkinson’s symptoms Date 19 May 2022 Research led by Cambridge University and part funded by Parkinson’s UK shows that a form of brain scan could help identify those at risk of specific Parkinson’s symptoms.
Clinical trial of world’s smallest deep brain stimulation device hits headlines Date 27 April 2022 A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
Progress made in partnership between pharma and people with Parkinson's Date 27 April 2022 A pioneering partnership between global biopharmaceutical company UCB, Parkinson’s UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.
New smartwatch has potential to enhance personalised Parkinson’s care Date 19 April 2022 As a new clinical trial begins, we explore the potential and next steps for a Parkinson’s watch that monitors symptoms.
